Selective extraction and effective separation of galactosylsphingosine (Psychosine) and glucosylsphingosine from other glycosphingolipids in pathological tissue samples

Neurochemical Research

Volumn 36, Issue 9, 2011, Pages 1612-1622

  Li, Yu Teh ^a   Li, Su Chen ^a   Buck, Wayne R ^b,c   Haskins, Mark E ^d   Wu, Sz Wei ^e   Khoo, Kay Hooi ^e   Sidransky, Ellen ^f   Bunnell, Bruce A ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c ABBOTT LABORATORIES   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Galactosylsphingosine; Gaucher disease; Glucosylsphingosine; Krabbe disease; Psychosine

Indexed keywords

ACETONE; GALACTOSYLCERAMIDE; GLUCOSYLCERAMIDE; GLUCOSYLSPHINGOSINE; GLYCOSPHINGOLIPID; PSYCHOSINE; SPHINGOSINE DERIVATIVE; SULFATIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; EXTRACTION; GAUCHER DISEASE; GLOBOID CELL LEUKODYSTROPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEPARATION TECHNIQUE; SPLEEN; THIN LAYER CHROMATOGRAPHY;

ADOLESCENT; ADULT; ANIMALS; BRAIN CHEMISTRY; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; DOGS; GAUCHER DISEASE; GLYCOSPHINGOLIPIDS; HUMANS; INFANT; LEUKODYSTROPHY, GLOBOID CELL; MACACA MULATTA; MICE; MICE, MUTANT STRAINS; PSYCHOSINE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPLEEN;

EID: 80755136700     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-010-0348-3     Document Type: Article

References (19)

1. Wenger DA, Suzuki K, Suzuki Y, Suzuki K (2001) Galactosylceramide lipidosis: Globoid cell leukodystrophy (Krabbe disease). In: Scriver CR, Beaudet AL, Valle D, Sly WS, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic basis of inherited diseases. McGraw-Hill, New York, pp 3669-3693
2. Beutler E, Grabowski GA (2001) Gaucher disease. In: Scriver CR, Beaudet AL, Valle D, Sly WS, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic basis of inherited diseases. McGraw-Hill, New York, pp 3635-3668
3. Svennerholm L, Vanier MT, Mansson JE (1980) Krabbe disease: A galactosylsphingosine (psychosine) lipidosis. J Lipid Res 21:53-64 (Pubitemid 10120438)
4. Igisu H, Suzuki K (1984) Analysis of galactosylsphingosine (psychosine) in the brain. J Lipid Res 25:1000-1006 (Pubitemid 15218786)
5. Stone DL, Tayebi N, Orvisky E et al (2000) Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat 15:181-188 (Pubitemid 30078409)
6. Anderson K, Li SC, Li YT (2000) Diphenylamine-aniline-phosphoric acid reagent, a versatile spray reagent for revealing glycoconjugates on thin-layer chromatography plates. Anal Biochem 287:337-339 (Pubitemid 32006246)
7. Merrill AH Jr, Wang E, Mullins RE et al (1988) Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal Biochem 171:373-381
8. Rosenheim O (1906) On the preparation of cholesterin from brain. J Physiol 34:104-105
9. Kanfer JN (1969) Preparation of gangliosides. Methods Enzymol 14:660-664
10. Baskin GB, Ratterree M, Davidson BB et al (1998) Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe disease) in rhesus monkeys (Macaca mulatta). Lab Anim Sci 48:476-482
11. Wenger DA, Victoria T, Rafi MA et al (1999) Globoid cell leukodystrophy in Cairn and West Highland White Terriers. J Hered 90:138-142 (Pubitemid 29067917)
12. Nozawa M, Iwamoto T, Tokoro T et al (1992) Novel procedure for measuring psychosine derivatives by an HPLC method. J Neurochem 59:607-609
13. Nilsson O, Mansson JE, Hakansson G et al (1982) The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease. Biochim Biophys Acta 712:453-463 (Pubitemid 13198976)
14. Orvisky E, Sidransky E, McKinney CE et al (2000) Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation. Pediatr Res 48:233-237 (Pubitemid 30497342)
15. Nilsson O, Svennerholm L (1982) Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem 39:709-718 (Pubitemid 12034962)
16. Orvisky E, Park JK, LaMarca ME et al (2002) Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: Correlation with phenotype and genotype. Mol Genet Metab 76:262-270
17. Whitfield PD, Sharp PC, Taylor R et al (2001) Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry. J Lipid Res 42:2092-2095 (Pubitemid 34001059)
18. Dasgupta S, Hogan EL (2001) Chromatographic resolution and quantitative assay of CNS tissue sphingoids and sphingolipids. J Lipid Res 42:301-308 (Pubitemid 32206843)
19. Bodennec J, Trajkovic-Bodennec S, Futerman AH (2003) Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphinglipids by N-acetylation with [3H]acetic anhydride. J Lipid Res 44:1413-1419 (Pubitemid 37279624)